Skip to main content
Header Nav
  • About
    • About Us
    • Vision and Values
    • Meet the Team
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Specializing in Injectables
Header Nav
  • About
    • About Us
    • Vision and Values
    • Meet the Team
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Investors Menu
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Policies and Charters
    • Board of Directors
    • Board Committee Assignments
    • Leadership Team
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Investor FAQs
  • Contact IR

Event Details

Eagle Pharmaceuticals Second Quarter 2023 Financial Results

8/8/23 at 8:30 AM EDT
Listen to Webcast
Change % Volume Data as of 12/22/2024 5:48 AM EST Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Policies and Charters
    • Board of Directors
    • Board Committee Assignments
    • Leadership Team
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Investor FAQs
  • Contact IR
Sidebar Links
  • Email Alerts
  • RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.

Footer Links
  • privacy policy
  • terms of use
  • sitemap
  • contact us

© 2024 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677